The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …

Variable domains of heavy chain-only antibodies (VHH), also known as nanobodies (Nbs),
are monomeric antigen-binding domains derived from the camelid heavy chain-only …

Targeted drug delivery is one of the attractive ways in which cancer treatment can
significantly reduce side effects. In the last two decades, the use of antibodies as a tool for …

Vaccine boosters and infection can facilitate the development of SARS-CoV-2 antibodies
with improved potency and breadth. Here, we observe superimmunity in a camelid …

In the last two years, the world encountered the SARS-CoV-2 virus, which is still dominating
the population due to the absence of a viable treatment. To eradicate the global pandemic …

Members of the Sarbecovirus subgenus of Coronaviridae have twice caused deadly threats
to humans. There is increasing concern about the rapid mutation of severe acute respiratory …

Although antibodies remain the most widely used tool for biomedical research, antibody
technology is not flawless. Innovative alternatives, such as Nanobody® molecules, were …

Introduction The immunological response to COVID-19 is only partly understood. It is
increasingly clear that the virus triggers an inappropriate host inflammatory reaction in …

Breast cancer is the most common type of cancer in women and the second leading cause
of cancer death in female. Triple-negative breast cancer has a more aggressive proliferation …

SARS-CoV-2 is the causative agent of COVID-19, which has greatly affected human health
since it first emerged. Defining the human factors and biomarkers that differentiate severe …